DBTRG-05MG（人腦膠質(zhì)母細(xì)胞瘤）
CBP60583
詢 價
索取STR
產(chǎn)品描述
產(chǎn)品數(shù)據(jù)庫
| I. General information | |
| Synonyms: | DBTRG-05MG |
| Background: | The DBTRG-O5MG (Denver Brain Tumor Research Group 05) cell line was established from tissue from a patient with glioblastoma multiforme who had been treated with local brain irradiation and multidrug chemotherapy. |
| Species: | Homo sapiens, human |
| Tissue: | brain |
| Disease: | glioblastoma |
| Gender: | Caucasian, female, 59 years |
| Morphology: | fibroblast |
| Growth Mode: | adherent |
| DNA Profile: | Amelogenin: X CSF1PO: 10,11 D13S317: 9 D16S539: 10,12 D5S818: 12,13 D7S820: 11 THO1: 7,8 TPOX: 8 vWA: 15,16 Our Cell Line Authentication Service |
| Culture Medium: |
DMEM+10%FBS DBTRG-05MG完全培養(yǎng)基，# CBP60583M |
| Cryopreservation medium: | 90%FBS+10%DMSO |
| Antigen Expression: | Class I antigen expressed |
| Receptor Expression: | epidermal growth factor (EGF) |
| Genes Expressed: | vimentin; S-100 protein; neuron specific enolase |
| Cellular Products: | vimentin; S-100 protein; neuron specific enolase |
| Comments: | The cells are negative for platelet derived growth factor (PDGF), neuronal cell adhesion molecule (NCAM), glial fibrillary acid protein (GFAP) and class II antigen (HLA DR). No loss of heterozygosity in the p53 tumor suppressor gene was detected. For more information, please contact us (4008-750-250). |
